Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins

Archive ouverte

Grogg, Julien | Vernet, Remi | Charrier, Emily | Urwyler, Muriel | Rohr, Olivier, Von | Saingier, Valentin | Courtout, Fabien | Lathuiliere, Aurelien | Gaudenzio, Nicolas | Engel, Adrien | Mach, Nicolas

Edité par CCSD ; Elsevier -

International audience. Encapsulated cell therapy holds a great potential to deliver sustained levels of highly potent therapeutic proteins to patients and improve chronic disease management. A versatile encapsulation device that is biocompatible, scalable, and easy to administer, retrieve, or replace has yet to be validated for clinical applications. Here, we report on a cargo-agnostic, macroencapsulation device with optimized features for protein delivery. It is compatible with adherent and suspension cells, and can be administered and retrieved without burdensome surgical procedures. We characterized its biocompatibility and showed that different cell lines producing different therapeutic proteins can be combined in the device. We demonstrated the ability of cytokine-secreting cells encapsulated in our device and implanted in human skin to mobilize and activate antigen-presenting cells, which could potentially serve as an effective adjuvant strategy in cancer immunization therapies. We believe that our device may contribute to cell therapies for cancer, metabolic disorders, and protein-deficient diseases.

Suggestions

Du même auteur

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model

Archive ouverte | Vernet, Rémi | CCSD

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with recurrences. Therefore, finding a vaccine for this virus became a priority for the scientific...

Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell proliferation

Archive ouverte | Rincon, Rafael | CCSD

International audience. Multiple myeloma is a plasma cell malignancy with poor prognosis despite the recent development of new therapeutic options. Histone deacetylase 6 (HDAC6) is overexpressed in multiple myeloma ...

CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine.

Archive ouverte | Wendland, Meike | CCSD

Small intestine plasmacytoid dendritic cells (pDC) are poorly characterized. Here, we demonstrate that intestinal pDC show the characteristic plasma cell-like morphology, and are recognized by antibodies against B220, Ly6c, 120G8,...

Chargement des enrichissements...